-
Mar 27, 2024 | 00091-x/abstract?rss=yes&sz=64)
jclinepi.com | Michael Colacci |Michelle Sholzberg |Kenneth J. Rothman |Michael Fralick
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
-
Feb 15, 2024 | 
onlinelibrary.wiley.com | Emily Bartsch |Saeha Shin |Kathleen Sheehan |Michael Fralick
1 BACKGROUND There is a bidirectional association between mental and physical health disorders, such that individuals with mental health disorders are at greater risk of common chronic medical conditions, such as hypertension, diabetes, and chronic obstructive pulmonary disease (Lin et al., 2011; Scott et al., 2016; Sporinova et al., 2019; Surveillance & Epidemiology Division, Public Health Agency of Canada et al., 2015).
-
Feb 8, 2024 | 
healthydebate.ca | Michael Fralick |Justin Boyle
https://healthydebate.ca/podcast-player/31520/episode-27-womens-heme-health.mp3Download file | Play in new window | Duration: 1:08:51Subscribe: Apple Podcasts | Google Podcasts | Spotify | StitcherWelcome back Rounds Table listeners!This week we have a very special episode on Women’s Heme Health.
-
Feb 8, 2024 | 
healthydebate.ca | Michael Fralick
https://healthydebate.ca/podcast-player/30557/episode-23-rapid-fire.mp3Download file | Play in new window | Duration: 29:29Subscribe: Apple Podcasts | Google Podcasts | Spotify | StitcherWelcome back Rounds Table listeners!We are back today with our Classic Rapid Fire format! Four papers … here we go!What is the optimal anticoagulation in patients with atrial fibrillation and a bioprosthetic mitral valve?
-
Feb 8, 2024 | 
healthydebate.ca | Michael Fralick
https://healthydebate.ca/podcast-player/32547/icymi-episode-27-rapid-fire-cardio.mp3Download file | Play in new window | Duration: 24:46Subscribe: Apple Podcasts | Google Podcasts | Spotify | StitcherWelcome back Rounds Table Listeners!We are back today with our Classic Rapid Fire format! This week, Mike and John do a Rapid Fire session to discuss two recent papers exploring cardiovascular disease risk.
-
Feb 8, 2024 | 
healthydebate.ca | Michael Fralick |Justin Boyle
https://healthydebate.ca/podcast-player/32884/episode-30-sglt2-inhibitors-and-glp-1-agonists-in-diabetes.mp3Download file | Play in new window | Duration: 15:34Subscribe: Apple Podcasts | Google Podcasts | Spotify | StitcherWelcome back Rounds Table Listeners!We are back today with our Classic Rapid Fire Podcast!This week, Mike and John do a Rapid Fire session to discuss two recent papers exploring the cardiovascular and renal benefits of two medications used in the management of diabetes.
-
Feb 8, 2024 | 
healthydebate.ca | Michael Fralick |Seema Marwaha
https://healthydebate.ca/podcast-player/28842/episode-20-rapid-fire-cardiology.mp3Download file | Play in new window | Duration: 26:01Subscribe: Apple Podcasts | Google Podcasts | Spotify | StitcherWelcome back Rounds Table Listeners!We are back today with our Classic Rapid Fire format! 4 papers…here we go! (0:33 – 7:02)2. Can SGLT2 inhibitors improve risk of heart failure or CV death among patients with reduced ejection fraction and heart failure? (7:03 – 12:46)3.
-
Nov 20, 2023 | 
cmaj.ca | Shohinee Sarma |Michael Fralick |Susan Tran
Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP1RA) is a weekly subcutaneous injection for adults with obesitySemaglutide was approved for adults with a body mass index (BMI) of 30 kg/m2 or greater, and those with a BMI of 27 kg/m2 or greater with 1 or more obesity-related comorbidities (e.g., hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea).
-
Aug 3, 2023 | 
kidneynews.org | Joel Topf |Michael Fralick |Thomas MacMillan
We read with interest Drs. Rondon-Berrios and Sterns' editorial regarding the treatment of hyponatremia in the May issue of ASN Kidney News (1) on the original investigation published in March 2023 in NEJM Evidence (2). This is a 10-year retrospective examination of hyponatremia at five hospitals in Toronto, Ontario, Canada.
-
Mar 25, 2023 | 
paperity.org | Benazir Hodzic-Santor |Chana A. Sacks |Tamara Van Bakel |Michael Fralick
PLOS ONE, Feb 2023 This is a preview of a remote PDF: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0281076&type=printable Benazir Hodzic-Santor, Chana A. Sacks, Tamara Van Bakel, Michael Fralick. , PLOS ONE, 2023, Volume 18, Issue 2, DOI: 10.1371/journal.pone.0281076
